Your trusted source for GLP-1 research, news, and patient insights.
3 posts in this category
A calm, plain-language explainer on SNAC, the absorption helper in oral semaglutide pills, and what the new 2026 study actually found.
A plain-language side-by-side of Foundayo and the Wegovy pill. Dosing, weight loss, side effects, and cost compared for 2026.
The FDA approved Foundayo (orforglipron) on April 1, 2026. Here is what the new once-daily GLP-1 pill actually changes for patients.
